Adaptogens for Pets: Ashwagandha, Rhodiola, and Honest Evidence

Last updated: May 23, 2026

The Adaptogen Category and the Honest Evidence Picture

Adaptogens are a class of herbs — ashwagandha (Withania somnifera), rhodiola (Rhodiola rosea), holy basil (Ocimum sanctum / tulsi), eleuthero or Siberian ginseng (Eleutherococcus senticosus), schisandra (Schisandra chinensis), reishi mushroom (Ganoderma lucidum), and others — historically used in human traditional medicine to support resilience to chronic stress, fatigue, convalescence, and HPA-axis dysregulation. They are now marketed extensively for pets in the integrative supplement market. The honest evidence picture is more modest than the marketing suggests: human adaptogen literature has notable methodological weaknesses, pet-specific data is thinner still, and most clinical use rests on mechanistic plausibility and practice-pattern observation rather than RCT validation.

This article walks through what adaptogens claim to do, where the limited evidence actually sits, which adaptogens AHVMA-credentialed integrative DVMs sometimes use and for what indications, and the specific cautions that matter — particularly thyroid interactions (ashwagandha), immune modulation in autoimmune disease, and drug interactions in patients receiving chemotherapy or specific cardiac medications. It is written for the rescue family encountering adaptogen recommendations from an integrative practitioner or considering supplement-aisle adaptogen products for an anxious or aging pet.

Evidence Tier — Honest and Limited

Evidence tier — ANECDOTAL for pets, with mechanistic plausibility and weak human literature support for several indications. The human adaptogen research base is heterogeneous, with significant methodological concerns: small trial sizes, mixed outcome measures, publication bias favoring positive findings, lack of standardized extracts across trials, and limited replication of individual positive trials. The pet-specific RCT base is essentially nonexistent for most adaptogens. Some integrative DVMs use adaptogens regularly in chronic-stress, convalescence, and mild HPA-axis adjunct indications based on extrapolation from human literature, practice pattern observation, and individual case response.

This honest framing matters because adaptogen marketing has outpaced adaptogen evidence by a wide margin. Owners encountering ashwagandha or rhodiola products marketed for “stress,” “anxiety,” “energy,” or “longevity” in pets should set expectations modestly. These herbs may help individual patients; they are not established therapies with strong RCT support comparable to silymarin for hepatic disease or NSAIDs for arthritis pain.

Ashwagandha (Withania somnifera) in Veterinary Use

Ashwagandha is the adaptogen with the most human research support among the popular options. Indications in human use include mild anxiety, mild thyroid hypofunction (ashwagandha modestly stimulates thyroid hormone production), stress-related fatigue, and convalescence. In veterinary integrative practice, some AHVMA-credentialed vets use ashwagandha for chronic stress responses, anxiety adjunct (alongside conventional anxiolytics, not as replacement), convalescence support after surgery or significant illness, and as one of several botanicals in adrenal-support protocols for Cushing’s-spectrum patients.

The thyroid effect requires explicit attention. Ashwagandha can stimulate thyroid hormone production, which is generally well-tolerated in euthyroid patients but problematic in hyperthyroid cats (see our hyperthyroid skin changes in cats guide for context on feline hyperthyroidism). Cats with diagnosed or suspected hyperthyroidism should not receive ashwagandha. Dogs and cats on thyroid hormone replacement should have ashwagandha use coordinated with the prescribing vet, as the additive thyroid stimulation can shift dosing requirements.

Rhodiola (Rhodiola rosea) and the Fatigue Literature

Rhodiola has human research support for mental fatigue, mild stress-related symptoms, and exercise tolerance. The veterinary use case is narrower than ashwagandha — some integrative DVMs use rhodiola in convalescence or in working dogs with stress-related fatigue patterns. Pet-specific evidence is essentially anecdotal. The herb is generally well-tolerated, with the most common adverse effect being mild GI upset or, paradoxically, agitation in some patients (rhodiola has mild stimulant properties at higher doses).

Rhodiola in anxious or hyperreactive patients is sometimes counterproductive — the mild stimulant effect can worsen rather than improve anxiety. For pets with documented anxiety, established therapies (see our dog anxiety medication options and cat anxiety medication guides) should be the foundation; rhodiola is at most a low-priority adjunct.

Holy Basil, Eleuthero, and Schisandra

Holy basil (tulsi) has human research support for mild stress and metabolic health. Veterinary use is anecdotal and limited to specific integrative practice patterns. Eleuthero (Siberian ginseng) has historical use for endurance and convalescence; pet-specific evidence is minimal. Schisandra has hepatic-supportive claims with mechanistic support but limited veterinary clinical research; it sometimes appears in integrative liver-support combinations alongside milk thistle and SAM-e.

The pattern across these herbs is consistent: mechanistic plausibility exists, traditional use spans centuries, human evidence is heterogeneous and limited, and pet-specific RCT evidence is essentially absent. They are tools that some integrative DVMs use; they are not established therapies with strong evidence comparable to first-line conventional treatments for the same indications.

Where Adaptogens May Fit in a Care Plan

The honest framing is that adaptogens are sometimes useful adjuncts in specific scenarios. Chronic-stress patients — long-stay shelter dogs adapting to home life, fearful adopted pets in early socialization, dogs with chronic generalized anxiety not fully resolved with conventional anxiolytics — may benefit from a multimodal approach including environmental management, behavioral training, anxiety medications, and adaptogen adjuncts. Senior pets with cognitive decline sometimes receive adaptogen-containing cognitive blends.

The pet recovering from a major illness or surgery — convalescence support, gradual return to baseline energy — is another use case some integrative DVMs prioritize. The Cushing’s-spectrum patient (see our cushings syndrome in dogs guide) where the integrative vet is supporting HPA-axis function alongside conventional management is a third scenario. In all cases, adaptogens are adjuncts, not standalone therapy.

Specific Cautions and Drug Interactions

Several specific cautions matter clinically. Thyroid interactions (ashwagandha stimulates thyroid; avoid in hyperthyroid cats and coordinate with thyroid hormone replacement). Immune modulation (most adaptogens have immune-modulating effects of unclear direction; use cautiously in autoimmune disease, atopic dermatitis, IBD, and during chemotherapy). Bleeding risk (several adaptogens have mild antiplatelet effects; pre-surgical washout is reasonable). Sedation interactions (rhodiola in particular may interact with sedating medications or, conversely, counteract them through mild stimulant properties).

Drug interactions to discuss with the prescribing vet include concurrent thyroid medications, immunosuppressives, chemotherapy agents, anticoagulants and antiplatelets, and any psychotropic medication. Pregnancy and lactation data are essentially absent for veterinary patients; most practitioners avoid adaptogens in pregnant or lactating animals.

Sourcing, Standardization, and Product Selection

Adaptogen quality varies dramatically. Look for: standardized extracts with stated active-compound percentages (for ashwagandha, look for withanolide percentage; for rhodiola, look for rosavin and salidroside percentages); the NASC quality seal where applicable; veterinary-brand products from established lines (Standard Process Veterinary Formulas, Animal Essentials, Rx Vitamins for Pets); transparent ingredient labeling without “proprietary blend” obfuscation. Avoid bulk powder from unverified online sources, multilevel-marketing brands with autoship pressure (see our supplement red flags guide), and products with vague active-ingredient disclosure.

Cost matters too. Adaptogen products span a wide price range, with veterinary-grade standardized extracts at the higher end. Generic supplement-aisle adaptogens may be substantially cheaper but with less reliable standardization and quality. For documented therapeutic intent, the price-quality tradeoff favors veterinary-grade products under practitioner supervision.

Setting Realistic Expectations

The honest conversation for owners considering adaptogens: these are not first-line treatments for any specific condition. They are adjuncts that may help individual pets in specific scenarios, with evidence that is mechanistic and anecdotal rather than RCT-validated. Set measurable response criteria with the integrative vet — behavioral observations, energy patterns, sleep, appetite, specific symptom changes — and reassess at six to twelve weeks. If no measurable improvement, change the protocol rather than continuing indefinitely.

If you are spending substantial money on adaptogen supplements without measurable response, the supplement is probably not contributing to your pet’s care. The integrative DVM should be willing to discontinue or change supplements that are not measurably helping, just as a conventional vet would discontinue a pharmaceutical that was not working. Open-ended supplementation without response monitoring is not good integrative practice.

Where Adaptogens Fit in the Broader Herbal Toolkit

Within the broader Western herbal landscape (see our Western veterinary herbal medicine overview), adaptogens are among the weaker-evidence categories. Stronger-evidence herbal options for specific indications include silymarin for hepatic disease, SAM-e for hepatic and emerging cognitive support, boswellia and curcumin for canine OA. Adaptogens occupy the adjunct-tier — used by some practitioners when first-line evidence-based approaches have been instituted and additional support is sought.

For anxious or fearful pets, behavior modification, environmental management, and conventional anxiety medications are the foundation. For senior pets with cognitive decline, multimodal cognitive management with selegiline, diet, environmental enrichment, and evidence-based supplements is the foundation. Adaptogens are layered on, not built around.

Frequently Asked Questions

Can I give my anxious dog ashwagandha instead of fluoxetine?

Not generally. Established anxiety medications have stronger evidence for clinically significant anxiety. Ashwagandha may have a role as an adjunct under integrative-vet guidance, but should not replace evidence-based therapy for documented anxiety disorders.

Are adaptogens safe for cats?

Some are, with veterinary guidance. Ashwagandha specifically should be avoided in hyperthyroid cats because of its thyroid-stimulating effect. Cat-specific dosing and product selection matter; do not extrapolate dog protocols to cats.

How do I know if an adaptogen is helping my pet?

Set specific measurable criteria with your vet before starting — behavior, energy, sleep, appetite, specific symptoms — and reassess at six to twelve weeks. If no measurable improvement, change the protocol. Vague “general wellness” claims are not measurable.

Can my pet take adaptogens during chemotherapy?

Only with explicit oncologist approval. Adaptogens have immune-modulating effects of unclear direction and may interact with chemotherapy agents. Do not add adaptogens to a chemotherapy protocol without coordination.

Are these herbs safe long-term?

Generally tolerated, with the cautions noted above. Most are used for defined treatment intervals rather than indefinitely. If a pet is doing well, periodic discontinuation trials help determine whether the herb is still contributing.